|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 19978 |
FusionGeneSummary for LPAR3_ST6GALNAC3 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: LPAR3_ST6GALNAC3 | Fusion gene ID: 19978 | Hgene | Tgene | Gene symbol | LPAR3 | ST6GALNAC3 | Gene ID | 23566 | 256435 |
| Gene name | lysophosphatidic acid receptor 3 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 | |
| Synonyms | EDG7|Edg-7|GPCR|HOFNH30|LP-A3|LPA3|RP4-678I3 | PRO7177|SIAT7C|ST6GALNACIII|STY | |
| Cytomap | 1p22.3 | 1p31.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | lysophosphatidic acid receptor 3LPA receptor 3LPA receptor EDG7LPA-3calcium-mobilizing lysophosphatidic acid receptor LP-A3endothelial cell differentiation gene 7endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 7lysoph | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3GalNAc alpha-2,6-sialyltransferase IIIST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltranST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3) | |
| Modification date | 20180519 | 20180523 | |
| UniProtAcc | Q9UBY5 | Q8NDV1 | |
| Ensembl transtripts involved in fusion gene | ENST00000440886, ENST00000370611, ENST00000491034, | ENST00000328299, ENST00000464140, | |
| Fusion gene scores | * DoF score | 1 X 1 X 1=1 | 5 X 5 X 3=75 |
| # samples | 1 | 5 | |
| ** MAII score | log2(1/1*10)=3.32192809488736 | log2(5/75*10)=-0.584962500721156 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: LPAR3 [Title/Abstract] AND ST6GALNAC3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | ST6GALNAC3 | GO:0006677 | glycosylceramide metabolic process | 17123352 |
| Tgene | ST6GALNAC3 | GO:0006687 | glycosphingolipid metabolic process | 17123352 |
| Tgene | ST6GALNAC3 | GO:0009100 | glycoprotein metabolic process | 17123352 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | BRCA | TCGA-A2-A0D0-01A | LPAR3 | chr1 | 85331068 | - | ST6GALNAC3 | chr1 | 77093137 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000440886 | ENST00000328299 | LPAR3 | chr1 | 85331068 | - | ST6GALNAC3 | chr1 | 77093137 | + |
| 5CDS-intron | ENST00000440886 | ENST00000464140 | LPAR3 | chr1 | 85331068 | - | ST6GALNAC3 | chr1 | 77093137 | + |
| Frame-shift | ENST00000370611 | ENST00000328299 | LPAR3 | chr1 | 85331068 | - | ST6GALNAC3 | chr1 | 77093137 | + |
| 5CDS-intron | ENST00000370611 | ENST00000464140 | LPAR3 | chr1 | 85331068 | - | ST6GALNAC3 | chr1 | 77093137 | + |
| 5UTR-3CDS | ENST00000491034 | ENST00000328299 | LPAR3 | chr1 | 85331068 | - | ST6GALNAC3 | chr1 | 77093137 | + |
| 5UTR-intron | ENST00000491034 | ENST00000464140 | LPAR3 | chr1 | 85331068 | - | ST6GALNAC3 | chr1 | 77093137 | + |
Top |
FusionProtFeatures for LPAR3_ST6GALNAC3 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| LPAR3 | ST6GALNAC3 |
| Receptor for lysophosphatidic acid (LPA), a mediator ofdiverse cellular activities. May play a role in the development ofovarian cancer. Seems to be coupled to the G(i)/G(o) and G(q)families of heteromeric G proteins. | Involved in the biosynthesis of ganglioside GD1A fromGM1B. Transfers CMP-NeuAc with an alpha-2,6-linkage to GalNAcresidue on NeuAc-alpha-2,3-Gal-beta-1,3-GalNAc of glycoproteinsand glycolipids. ST6GalNAcIII prefers glycolipids to glycoproteins(By similarity). {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for LPAR3_ST6GALNAC3 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for LPAR3_ST6GALNAC3 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| LPAR3 | APP, LMNA | ST6GALNAC3 | CAMK1, SAAL1, SELENBP1, PON2, DSG4, PKP3, PTCH1, SCN3B, GGT7, CLEC2D, KLRG2, TMED6, DUSP14, NCEH1 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for LPAR3_ST6GALNAC3 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for LPAR3_ST6GALNAC3 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|